Hydroxamate-based peptide inhibitors of matrix metalloprotease 2

Biochimie

Volumn 87, Issue 3-4 SPEC. ISS., 2005, Pages 385-392

  Jani, Márton ^a   Tordai, Hedvig ^a   Trexler, Mária ^a   Bányai, László ^a   Patthy, László ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Drug design; Gelatinase A; Matrix metalloproteinases; Tumor metastasis

Indexed keywords

AMINO ACID; COLLAGEN; ENZYME INHIBITOR; GELATINASE A; HYDROXAMIC ACID;

AMINO ACID SEQUENCE; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG INHIBITION; DRUG PROTEIN BINDING; DRUG SELECTIVITY; ENZYME ACTIVE SITE; ENZYME INHIBITION; HUMAN; IC 50; ISOMERISM; PHAGE DISPLAY; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

EID: 15244355692     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biochi.2004.09.008     Document Type: Short Survey

References (42)

1. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry Circ. Res. 92 8 2003 827 839
2. H. Kai, H. Ikeda, H. Yasukawa, M. Kai, Y. Seki, and F. Kuwahara Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes J. Am. Coll. Cardiol. 32 1998 368 372
3. S. Ye Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases Matrix Biol. 19 2000 623 629
4. A.R. Morgan, B. Zhang, W. Tapper, A. Collins, and S. Ye Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease J. Mol. Med. 81 2003 321 326
5. C.M. Overall Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites Mol. Biotechnol 22 2002 51 86
6. M. Pavlaki, and S. Zucker Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials Cancer Metastasis Rev. 22 2003 177 203
7. I.E. Collier, S.M. Wilhelm, A.Z. Eisen, B.L. Marmer, G.A. Grant, and J.L. Seltzer H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen J. Biol. Chem. 263 1988 6579 6587
8. S.M. Wilhelm, I.E. Collier, B.L. Marmer, A.Z. Eisen, G.A. Grant, and G.I. Goldberg SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages J. Biol. Chem. 264 1989 17213 17221
9. L. Bányai, and L. Patthy Evidence for the involvement of type II domains in collagen binding by 72:kDa type IV procollagenase FEBS Lett. 282 1991 23 25
10. B. Steffensen, U.M. Wallon, and C.M. Overall Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase J. Biol. Chem. 270 1995 11555 11566
11. I.E. Collier, P.A. Krasnov, A.Y. Strongin, H. Birkedal-Hansen, and G.I. Goldberg Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase J. Biol. Chem. 267 1992 6776 6781
12. L. Bányai, H. Tordai, and L. Patthy The gelatin-binding site of human 72:kDa type IV collagenase (gelatinase A) Biochem. J. 298 1994 403 407
13. G. Murphy, Q. Nguyen, M.I. Cockett, S.J. Atkinson, J.A. Allan, and C.G. Knight Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant J. Biol. Chem. 269 1994 6632 6636
14. J.A. Allan, A.J. Docherty, P.J. Barker, N.S. Huskisson, J.J. Reynolds, and G. Murphy Binding of gelatinases A and B to type-I collagen and other matrix components Biochem. J. 309 1995 299 306
15. T.J. O'Farrell, and T. Pourmotabbed The fibronectin-like domain is required for the type V and XI collagenolytic activity of gelatinase B Arch. Biochem. Biophys. 354 1998 24 30
16. T.J. O'Farrell, and T. Pourmotabbed Identification of structural elements important for matrix metalloproteinase type V collagenolytic activity as revealed by chimeric enzymes. Role of fibronectin-like domain and active site of gelatinase B J. Biol. Chem. 275 2000 27964 27972
17. Q.Z. Ye, L.L. Johnson, A.E. Yu, and D. Hupe Reconstructed 19:kDa catalytic domain of gelatinase A is an active proteinase Biochemistry 34 1995 4702 4708
18. C.L. Librach, Z. Werb, M.L. Fitzgerald, K. Chiu, N.M. Corwin, and R.A. Esteves 92-kD type IV collagenase mediates invasion of human cytotrophoblasts J. Cell Biol. 113 1991 437 449
19. W.G. Stetler-Stevenson Type IV collagenases in tumor invasion and metastasis Cancer Metastasis Rev. 9 1990 289 303
20. W.G. Stetler-Stevenson, L. Liotta, and D.E. Kleiner Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis FASEB J. 15 1993 1434 1441
21. T. Itoh, M. Tanioka, H. Yoshida, T. Yoshioka, H. Nishimoto, and S. Itohara Reduced angiogenesis and tumor progression in gelatinase A-deficient mice Cancer Res. 58 1998 1048 1051
22. T. Itoh, M. Tanioka, H. Matsuda, H. Nishimoto, T. Yoshioka, and R. Suzuki Experimental metastasis is suppressed in MMP-9-deficient mice Clin. Exp. Metastasis 17 1999 177 181
23. R. Pyo, J.K. Lee, J.M. Shipley, J.A. Curci, D. Mao, and S.J. Ziporin Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms J. Clin. Invest. 105 11 2000 1641 1649
24. G.M. Longo, W. Xiong, T.C. Greiner, Y. Zhao, N. Fiotti, and B.T. Baxter Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms J. Clin. Invest 110 5 2002 625 632
25. H. Tordai, and L. Patthy The gelatin-binding site of the second type-II domain of gelatinase A/MMP-2 Eur. J. Biochem. 259 1999 513 518
26. K. Briknarova, A. Grishaev, L. Bányai, H. Tordai, L. Patthy, and M. Llinas The second type II module from human matrix metalloproteinase 2: structure, function and dynamics Struct. Fold. Des. 7 1999 1235 1245
27. K. Briknarova, M. Gehrmann, L. Bányai, H. Tordai, L. Patthy, and M. Llinas Gelatin-binding region of human matrix metalloproteinase-2: solution structure, dynamics, and function of the COL-23 two-domain construct J. Biol. Chem. 276 2001 27613 27621
28. M. Gehrmann, K. Briknarova, L. Bányai, L. Patthy, and M. Llinas The col-1 module of human matrix metalloproteinase-2 (MMP-2): structural/functional relatedness between gelatin-binding fibronectin type II modules and lysine-binding single domains Biol. Chem. 383 2002 137 148
29. L. Bányai, H. Tordai, and L. Patthy Structure and domain-domain interactions of the gelatin binding site of human 72-kilodalton type IV collagenase (gelatinase A, matrix metalloproteinase 2) J. Biol. Chem. 271 1996 12003 12008
30. E. Morgunova, A. Tuuttila, U. Bergmann, M. Isupov, Y. Lindqvist, and G. Schneider Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed Science 284 1999 1667 1670
31. G.A. Bannikov, T.V. Karelina, I.E. Collier, B.L. Marmer, and G.I. Goldberg Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide J. Biol. Chem. 277 2002 16022 16027
32. R. Hoekstra, F.A. Eskens, and J. Verweij Matrix metalloproteinase inhibitors: current developments and future perspectives The Oncologist 6 2001 415 427
33. C.M. Overall, and C. Lopez-Otin Strategies for MMP inhibition in cancer: innovations for the post-trial era Nat. Rev. Cancer 2 2002 657 672
34. L.M. Coussens, B. Fingleton, and L.M. Matrisian Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295 2002 2387 2392
35. N. Ramnath, and P.J. Creaven Matrix metalloproteinase inhibitors Curr. Oncol. Rep. 6 2 2004 96 102
36. S.B. Shuker, P.J. Hajduk, R.P. Meadows, and S.W. Fesik Discovering high-affinity ligands for proteins SAR by NMR, Science 274 1996 1531 1534
37. A. Berton, V. Rigot, E. Huet, M. Decarme, Y. Eeckhout, L. Patthy, and G. Godeau Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids J. Biol. Chem. 276 2001 20458 20465
38. M. Trexler, K. Briknarova, M. Gehrmann, M. Llinas, and L. Patthy Peptide ligands for the fibronectin type II modules of matrix metalloproteinase 2 (MMP-2) J. Biol. Chem. 278 2003 12241 12246
39. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 259 1970 680 685
40. F.J. Woessner Quantification of matrix metalloproteinases in tissue samples A.J. Barrett Methods in Enzymology 248 1995 510 528
41. R.Z. Kramer, L. Vitagliano, J. Bella, R. Berisio, L. Mazzarella, and B. Brodsky X-ray crystallographic determination of a collagen-like peptide with the repeating sequence (Pro-Pro-Gly) J. Mol. Biol. 280 1998 623 638
42. R. Berisio, L. Vitagliano, L. Mazzarella, and A. Zagari Crystal structure of the collagen triple helix model [(Pro-Pro-Gly)(10)](3) Protein Sci. 11 2002 262 270